Navigation Links
Hospira Reports First-Quarter 2012 Results
Date:5/1/2012

ly certain products to customers. These charges are directly associated with Hospira's response to the United States Food and Drug Administration ("FDA") 2010 warning letter and subsequent Form 483 observations and charges related to Hospira's comprehensive device product review and certain device related remediation activities.(C)

Capacity expansion related charges reported in Cost of products sold include start-up charges related to manufacturing capacity expansion in India.Three months ended March 31, 2011 Reconciliation of GAAP to Non-GAAP Financial Measures:Gross Profit (1)Income From

OperationsNet Income (2)Diluted EPSGAAP financial measures$
399.1$
3.8$
49.9$
.88Specified items:   Project Fuel and related charges (A)5.09.66.30.04   Facilities Optimization charges (B)0.81.10.70.01   Amortization and impairment of certain intangible assets (C)19.421.114.50.09   Other restructuring charges (D)-7.85.80.03   Settlement of IRS tax audit benefit (E)--(19.7)(0.12)Adjusted financial measures (3)$
424.3$
203.4$
57.5$
.93GAAP results for the three months ended March 31, 2011 include:(A)

Project Fuel and related charges: $5.0 million reported in Cost of products sold, $3.4 million reported in Restructuring, impairment and (gain) on disposition of assets, net and $1.2 million reported in Selling, general and administrative. Project Fuel initiatives include costs for process optimization implementation, severance and other employee benefits, exit costs, and other asset charges.(B)

Facilities Optimization charges: $0.8 million reported in Cost of products sold and $0.3 million reported in Restructuring, impairment and (gain) on disposition of asset
'/>"/>

SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. Hospira Joins the Generic Pharmaceutical Association
3. Hospira Works With FDA to Help Avert Methotrexate Shortage; Shipping One Months Supply of New Product Immediately and on Track to Ensure Sustainable Supply
4. Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
5. Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 Projections
6. Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012
7. Hospira Reports Third-Quarter 2011 Results
8. Hospira Announces Certain Preliminary Third-Quarter 2011 Results
9. Hospira to Host Conference Call for Third-Quarter 2011 Results
10. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
11. Hospira to Host 2011 Investor Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)...  Landauer, Inc. (NYSE: LDR ), a ... monitoring, outsourced medical physics services and high quality medical ... , its President and Chief Executive Officer, will be ... as a member of the Board of Directors, effective ... on an interim basis by Michael T. Leatherman ...
(Date:8/21/2014)... --  Memorial Hermann Health System and The University ... new partnership to provide a new level of specialized breast ... the greater Houston area. ... provider of professional breast radiology services for five of Memorial ... The Woodlands , Northeast, Southwest and ...
(Date:8/21/2014)... , Aug. 21, 2014 The spinal column is ... human body. Signals carried to and from the brain through ... and nervous system. Injury or ailment here can be life ... a loss of control over their body. Though back injury ... person,s life, there are more options available to make things ...
Breaking Medicine Technology:Landauer, Inc. Announces Executive Management Change 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2
... Pharma, Inc. (NYSE AMEX: DDD ) today reported ... 30, 2010.Stephen J. Turner, SCOLR Pharma,s President and CEO, said, ... to continue executing the plans for our extended release nutritional ... in the last quarter. "We believe that ...
... 2010 Hologic, Inc. (Nasdaq: HOLX ) ... following conferences: Rob Cascella, President and Chief ... Conference in New York City on Thursday, December 2, ... to listen to the live audio webcast of Hologic,s ...
Cached Medicine Technology:SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2010 Financial Results 7Hologic to Participate in Three Investor Conferences 2
(Date:8/22/2014)... DC (PRWEB) August 22, 2014 Paying ... little easier in the coming year for four nurse ... the National League for Nursing Foundation for Nursing ... – will share $28,000, $10,000 more than in 2013, ... Ann Kerr Endowment and Elizabeth Isaac Marcil Endowment Funds, ...
(Date:8/22/2014)... August 22, 2014 Eagerly embracing intended ... fertility destination, and now offers the top male infertility ... infertility specialists. The fertility network of IVFinMexico.com ... to world-class reproductive care, female and male infertility, advanced ... to the standards so eminently set by company CEO ...
(Date:8/22/2014)... 2014 (HealthDay News) -- An intensive effort to sterilize feral ... shelter in Florida and euthanized, a new study reveals. ... slow their intake into animal control," Dr. Julie Levy, a ... of Veterinary Medicine, said in a university news release. ... a big impact," she explained, "so we wanted to pick ...
(Date:8/22/2014)... A national leader in home delivery of medical supplies, ... grow. , Headquarters for the provider of sterile-use catheters and ... 8516 N.W. Expressway in Oklahoma City. , Rapid growth ... places to work by OKCBiz magazine – demanded more space ... the past two years, and staff count grew 30 percent ...
(Date:8/22/2014)... Home Care Assistance of Centennial , ... is proud to announce the next installment in its ... feature Dr. Suzanne Steinbaum, attending cardiologist and Director of ... York City, National Spokesperson for the American Heart Association’s ... the issues surrounding women and heart disease, what heart ...
Breaking Medicine News(10 mins):Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 2Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 3Health News:Mexico Now Offers Top Program for Couples Suffering from Male Infertility 4Health News:Neutering Project Curbed Feral Cat Population 2Health News:Fast-growing 180 Medical Moves Into New 60,000-square-foot Office in Oklahoma City 2Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Centennial to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3
... FRANCISCO, Jan. 28 Rodan + Fields Dermatologists, the,clinical skincare ... and Kathy Fields, M.D., is pleased to,announce the recent addition ... "Rodan + Fields is the most exciting ... retail, we should expect their future to,be bright," says Henry. ...
... The International Medical Interpreters Association (IMIA) unveiled ... its organization. "Our revised bylaws do not stipulate ... distributed among different states and this initiative will ... President.The organization will now have a key representative ...
... Jan. 28 Dr. Michael Forster of the ... of the University of Southern California,s ... may not be a key to living longer. ... researchers were recently published in several scientific journals ...
... 28 The Frost & Sullivan ,2009 European ... Award, is presented to VTS Medical Systems, LLC, ... needs of European hospitals with its value-added products ... ergonomically designed VividImage(R) series, the company is set ...
... 28 Cardiogenesis Corporation (Pink Sheets: CGCP), ... ischemic cardiac disease and the market leader ... sponsored an educational symposium titled "Advancements in ... attended by over 40 cardiothoracic surgeons.The Program ...
... Resubmission Within 60 Days-MISSISSAUGA, ON, Jan. 28 /PRNewswire-FirstCall/ ... drug development company focused on the research and ... the skin using its topical and transdermal drug ... completed all of the studies that will support ...
Cached Medicine News:Health News:Direct Selling Luminary, Robert M. Henry, Partners With Rodan + Fields(R) Dermatologists as Strategic Business Advisor 2Health News:International Medical Interpreter Association Appoints IMIA State Representatives 2Health News:UNT Health Science Center Researchers Discover Eating Less May Not Increase Life Expectancy 2Health News:UNT Health Science Center Researchers Discover Eating Less May Not Increase Life Expectancy 3Health News:Frost & Sullivan Bestows Product Line Strategy Leadership Award to VTS Medical Systems, LLC 2Health News:Frost & Sullivan Bestows Product Line Strategy Leadership Award to VTS Medical Systems, LLC 3Health News:Frost & Sullivan Bestows Product Line Strategy Leadership Award to VTS Medical Systems, LLC 4Health News:Cardiogenesis Announces Successful Educational Symposium at Society of Thoracic Surgeons Meeting in San Francisco 2Health News:Cardiogenesis Announces Successful Educational Symposium at Society of Thoracic Surgeons Meeting in San Francisco 3Health News:Cardiogenesis Announces Successful Educational Symposium at Society of Thoracic Surgeons Meeting in San Francisco 4Health News:Nuvo Research Announces Successful Completion Of All Pennsaid(R) Studies 2Health News:Nuvo Research Announces Successful Completion Of All Pennsaid(R) Studies 3Health News:Nuvo Research Announces Successful Completion Of All Pennsaid(R) Studies 4
Calibration plasmas for Assays of Low Molecular Weight Heparins (LMWH)using the Anti-Xa method on STA© Analyzers....
Control Plasma for Assays of Low MolecularWeight Heparins (LMWH) using Anti-Xa Method on STA© Analyzers....
PT, PTT, Fibrinogetn & TT Normal and Abnormal Controls...
ApolipoproteinA-1 & B Calibrator...
Medicine Products: